Related references
Note: Only part of the references are listed.Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19 A Living Systematic Review
Adrian V. Hernandez et al.
ANNALS OF INTERNAL MEDICINE (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine
Paul Elias Alexander et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Covid-19: 146 researchers raise concerns over chloroquine study that halted WHO trial
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra et al.
LANCET (2020)
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro et al.
JAMA CARDIOLOGY (2020)
COVID-19: keep up with latest papers
Qingyu Chen et al.
NATURE (2020)
Temporal dynamics in viral shedding and transmissibility of COVID-19
Xi He et al.
NATURE MEDICINE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
The pandemic's first major research scandal erupts
Kelly Servick et al.
SCIENCE (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Michael S. Avidan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Critical appraisal of nonrandomized studies-A review of recommended and commonly used tools
Joan M. Quigley et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2019)
Research waste is still a scandal-an essay by Paul Glasziou and Iain Chalmers
Paul Glasziou et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Methodological quality and synthesis of case series and case reports
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
The Rush to Publication An Editorial and Scientific Mistake
Howard Bauchner
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Evidence based medicine manifesto for better healthcare
Carl Heneghan et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Evidence based medicine manifesto for better healthcare
Carl Heneghan et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Methodological Rigor in Preclinical Cardiovascular Studies Targets to Enhance Reproducibility and Promote Research Translation
F. Daniel Ramirez et al.
CIRCULATION RESEARCH (2017)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Reducing waste from incomplete or unusable reports of biomedical research
Paul Glasziou et al.
LANCET (2014)
Increasing value and reducing waste: addressing inaccessible research
An-Wen Chan et al.
LANCET (2014)
Increasing value and reducing waste in biomedical research regulation and management
Rustam Al-Shahi Salman et al.
LANCET (2014)
How to increase value and reduce waste when research priorities are set
Iain Chalmers et al.
LANCET (2014)
Increasing value and reducing waste in research design, conduct, and analysis
John P. A. Ioannidis et al.
LANCET (2014)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
The Levels of Evidence and Their Role in Evidence-Based Medicine
Patricia B. Burns et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Avoidable waste in the production and reporting of research evidence
Iain Chalmers et al.
LANCET (2009)
1918 Influenza: A Winnebago County, Wisconsin Perspective
Teri Shors et al.
CLINICAL MEDICINE & RESEARCH (2009)
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography
Simon Sanderson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)
Share Paper
